CTAG2 cDNA ORF clone, Homo sapiens(human)

Gene
Clones
gRNAs

Summary

Gene Symbol	CTAG2
Entrez Gene ID	30848
Full Name	cancer/testis antigen 2
Synonyms	CAMEL,CT2,CT6.2,CT6.2a,CT6.2b,ESO2,LAGE-1,LAGE2B
General protein information	Preferred Names cancer/testis antigen 2 Names cancer/testis antigen 2 CTL-recognized antigen on melanoma LAGE-1a protein autoimmunogenic cancer/testis antigen NY-ESO-2 cancer/testis antigen 6.2 cancer/testis antigen family 6, member 2a cancer/testis antigen family 6, member 2b l antigen family member 1
Gene Type	protein-coding
Organism	Homo sapiens(human)
Genome	Chromosome: X Map Location: Xq28
Summary	This gene encodes an autoimmunogenic tumor antigen that belongs to the ESO/LAGE family of cancer-testis antigens. This protein is expressed in a wide array of cancers including melanoma, breast cancer, bladder cancer and prostate cancer. This protein is also expressed in normal testis tissue. An alternative open reading frame product of this gene has been described in PMID:10399963. This alternate protein, termed CAMEL, is a tumor antigen that is recognized by melanoma-specific cytotoxic T-lymphocytes. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Sep 2013].
Disorder MIM:	300396

mRNA and Protein(s)

mRNA	Protein	Name
NM_020994.4	NP_066274.2	cancer/testis antigen 2 isoform LAGE-1b
NM_020994.5	NP_066274.2	cancer/testis antigen 2 isoform LAGE-1b
NM_172377.4	NP_758965.2	cancer/testis antigen 2 isoform LAGE-1a

Pathways from BioSystems

Homologies

Pan troglodytes (chimpanzee)	LOC465964	XP_521360.3
	CTAG2	XP_001095804.2
Homo sapiens (human)	CTAG2	NP_758965.2

Gene Ontology
Bibliography

Related articles in PubMed

Reexpression of LSAMP inhibits tumor growth in a preclinical osteosarcoma model.
Bar?y T, Kresse SH, Sk?rn M, Stabell M, Castro R, Lauvrak S, Llombart-Bosch A, Myklebost O, Meza-Zepeda LA
Molecular cancer1393(2014 Apr)

Genome-wide association analysis of red blood cell traits in African Americans: the COGENT Network.
Chen Z, Tang H, Qayyum R, Schick UM, Nalls MA, Handsaker R, Li J, Lu Y, Yanek LR, Keating B, Meng Y, van Rooij FJ, Okada Y, Kubo M, Rasmussen-Torvik L, Keller MF, Lange L, Evans M, Bottinger EP, Linderman MD, Ruderfer DM, Hakonarson H, Papanicolaou G, Zonderman AB, Gottesman O, , , Thomson C, Ziv E, Singleton AB, Loos RJ, Sleiman PM, Ganesh S, McCarroll S, Becker DM, Wilson JG, Lettre G, Reiner AP
Human molecular genetics22(12)2529-38(2013 Jun)

NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine.
Pollack SM, Li Y, Blaisdell MJ, Farrar EA, Chou J, Hoch BL, Loggers ET, Rodler E, Eary JF, Conrad EU 3rd, Jones RL, Yee C
PloS one7(2)e32165(2012)

Evaluation of LAGE-1 and NY-ESO-1 expression in multiple myeloma patients to explore possible benefits of their homology for immunotherapy.
de Carvalho F, Vettore AL, Inaoka RJ, Karia B, Andrade VC, Gnjatic S, Jungbluth AA, Colleoni GW
Cancer immunity111(2011 Jan)

Cancer/testis antigens: an expanding family of targets for cancer immunotherapy.
Scanlan MJ, Gure AO, Jungbluth AA, Old LJ, Chen YT
Immunological reviews18822-32(2002 Oct)

GeneRIFs: Gene References Into Functions What's a GeneRIF?

The tumor suppressor function of LSAMP is most likely exerted by reducing the proliferation rate of the tumor cells, possibly by indirectly upregulating one or more of the genes HES1, CTAG2 or KLF10.
Title: Reexpression of LSAMP inhibits tumor growth in a preclinical osteosarcoma model.

NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine
Title: NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine.

LAGE-1a and NY-ESO-1 homology cannot be easily exploited in an anti-NY-ESO-1 vaccine given the low frequency of protein expression detected by IHC or serum analysis.
Title: Evaluation of LAGE-1 and NY-ESO-1 expression in multiple myeloma patients to explore possible benefits of their homology for immunotherapy.

Spontaneous LAGE-1-specific CD4-positive T cells isolated from patients with advanced LAGE-1-positive/NY-ESO-1-positive melanoma are directed against three promiscuous and immunodominant epitopes.
Title: Epitope hierarchy of spontaneous CD4+ T cell responses to LAGE-1.

We evaluated the correlations among the expression levels of NY-ESO-1, LAGE-1 and SSX-1 and clinical parameters in hepatocellular carcinoma patients
Title: Comparisons for detecting NY-ESO-1 mRNA expression levels in hepatocellular carcinoma tissues.

The following CTAG2 gene cDNA ORF clone sequences were retrieved from the NCBI Reference Sequence Database (RefSeq). These sequences represent the protein coding region of the CTAG2 cDNA ORF which is encoded by the open reading frame (ORF) sequence. ORF sequences can be delivered in our standard vector, pcDNA3.1⁺/C-(K)DYK or the vector of your choice as an expression/transfection-ready ORF clone. Not the clone you want? Click here to find your clone.

***CloneID	Accession No.	Definition	**Vector	*Turnaround time	Price (USD)
OHu00450	NM_172377.4 Latest version!	Homo sapiens cancer/testis antigen 2 (CTAG2), transcript variant 1, mRNA.	pcDNA3.1-C-(k)DYK or customized vector	in pcDNA3.1-C-(k)DYK	$49.50-$69.30 $99.00
OHu20786	NM_020994.5 Latest version!	Homo sapiens cancer/testis antigen 2 (CTAG2), transcript variant 2, mRNA.	pcDNA3.1-C-(k)DYK or customized vector	in pcDNA3.1-C-(k)DYK	$154.50-$216.30 $309.00
View Old Accession Versions >>
OHu20786	NM_020994.4	Homo sapiens cancer/testis antigen 2 (CTAG2), transcript variant 2, mRNA.	pcDNA3.1-C-(k)DYK or customized vector	in pcDNA3.1-C-(k)DYK	$154.50-$216.30 $309.00
Hide Old Accession Versions >>

ORF Online Only Promotion

Next-day Shipping ORF Clones ( in default vector with tag)
1 Clone	30% OFF
2-4 Clone	40% OFF
5 or more Clone	50% OFF
All Other ORF Clones
30% OFF

*Business Day

** You may select a custom vector to replace pcDNA3.1+/C-(K)DYK after clone is added to cart.

** GenScript guarantees 100% sequence accuracy of all synthetic DNA constructs we deliver, but we do not guarantee protein expression in your experimental system. Protein expression is influenced by many factors that may vary between experiments or laboratories. In addition, please pay attention to the signal peptide, propeptide and transit peptide in target ORF, which may affect the choice of vector (N/C terminal tag vector).

***One clone ID might be correlated to multiple accession numbers, which share the same CDS sequence.

Reference Sequences (Refseq)

CTAG2 ( NM_172377.4 ) cDNA ORF clone, Homo sapiens(human) -> NP_758965.2 Homo sapiens cancer/testis antigen 2 (CTAG2), transcript variant 1, mRNA.

Price & Availability↑

CloneID	OHu00450
Clone ID Related Accession (Same CDS sequence)	NM_172377.4
Accession Version	NM_172377.4 Latest version!	Documents for ORF clone product in default vector
Sequence Information	ORF Nucleotide Sequence (Length: 543bp) Protein sequence SNP
Vector	pcDNA3.1-C-(k)DYK or customized vector	User Manual
Clone information	Clone Map	MSDS
Tag on pcDNA3.1⁺/C-(K)DYK	C terminal DYKDDDDK tags
ORF Insert Method	CloneEZ™ Seamless cloning technology
Insert Structure	linear
Update Date	2019-09-24
Organism	Homo sapiens(human)
Product	cancer/testis antigen 2 isoform LAGE-1a
Comment	Comment: REVIEWED REFSEQ: This record has been curated by NCBI staff. The reference sequence was derived from AJ223040.1 and BC113998.1. On Sep 14, 2013 this sequence version replaced NM_172377.3. Transcript Variant: This variant (1) encodes isoform LAGE-1a (also known as LAGE-1S). Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Gene record to access additional publications. ##Evidence-Data-START## Transcript exon combination :: AJ012834.1, AJ223041.1 [ECO:0000332] RNAseq introns :: single sample supports all introns SAMEA1968968 [ECO:0000348] ##Evidence-Data-END## ##RefSeq-Attributes-START## RefSeq Select criteria :: based on expression ##RefSeq-Attributes-END## COMPLETENESS: complete on the 3' end.

ATGCAGGCCG AAGGCCGGGG CACAGGGGGT TCGACGGGCG ATGCTGATGG CCCAGGAGGC 
CCTGGCATTC CTGATGGCCC AGGGGGCAAT GCTGGCGGCC CAGGAGAGGC GGGTGCCACG 
GGCGGCAGAG GTCCCCGGGG CGCAGGGGCA GCAAGGGCCT CGGGGCCGAG AGGAGGCGCC 
CCGCGGGGTC CGCATGGCGG TGCCGCTTCT GCGCAGGATG GAAGGTGCCC CTGCGGGGCC 
AGGAGGCCGG ACAGCCGCCT GCTTGAGTTG CACATCACGA TGCCTTTCTC GTCGCCCATG 
GAAGCGGAGC TGGTCCGCAG GATCCTGTCC CGGGATGCCG CACCGCTCCC CCGACCAGGG 
GCGGTTCTGA AGGACTTCAC CGTGTCCGGC AACCTACTGT TTATCCGACT GACTGCTGCA 
GACCACCGCC AACTGCAGCT CTCCATCAGC TCCTGTCTCC AGCAGCTTTC CCTGTTGATG 
TGGATCACGC AGTGCTTTCT GCCCGTGTTT TTGGCTCAGG CTCCCTCAGG GCAGAGGCGC 
TAA

The stop codons will be deleted if pcDNA3.1⁺/C-(K)DYK vector is selected.

RefSeq	NP_758965.2
CDS	65..607
Translation	MQAEGRGTGGSTGDADGPGGPGIPDGPGGNAGGPGEAGATGGRGPRGAGAARASGPRGGAPRGPHGGAASAQDGRCPCGARRPDSRLLELHITMPFSSPMEAELVRRILSRDAAPLPRPGAVLKDFTVSGNLLFIRLTAADHRQLQLSISSCLQQLSLLMWITQCFLPVFLAQAPSGQRR

Target ORF information:

RefSeq Version	NM_172377.4
Organism	Homo sapiens(human)
Definition	Homo sapiens cancer/testis antigen 2 (CTAG2), transcript variant 1, mRNA.

Target ORF information:

Epitope	DYKDDDDK
Bacterial selection	AMP^R
Mammalian selection	Neo^R
Vector	pcDNA3.1⁺/C-(K)DYK

NM_172377.4

ORF Insert Sequence:

ATGCAGGCCG AAGGCCGGGG CACAGGGGGT TCGACGGGCG ATGCTGATGG CCCAGGAGGC 
CCTGGCATTC CTGATGGCCC AGGGGGCAAT GCTGGCGGCC CAGGAGAGGC GGGTGCCACG 
GGCGGCAGAG GTCCCCGGGG CGCAGGGGCA GCAAGGGCCT CGGGGCCGAG AGGAGGCGCC 
CCGCGGGGTC CGCATGGCGG TGCCGCTTCT GCGCAGGATG GAAGGTGCCC CTGCGGGGCC 
AGGAGGCCGG ACAGCCGCCT GCTTGAGTTG CACATCACGA TGCCTTTCTC GTCGCCCATG 
GAAGCGGAGC TGGTCCGCAG GATCCTGTCC CGGGATGCCG CACCGCTCCC CCGACCAGGG 
GCGGTTCTGA AGGACTTCAC CGTGTCCGGC AACCTACTGT TTATCCGACT GACTGCTGCA 
GACCACCGCC AACTGCAGCT CTCCATCAGC TCCTGTCTCC AGCAGCTTTC CCTGTTGATG 
TGGATCACGC AGTGCTTTCT GCCCGTGTTT TTGGCTCAGG CTCCCTCAGG GCAGAGGCGC 
TAA

The stop codons will be deleted if pcDNA3.1⁺/C-(K)DYK vector is selected.

CTAG2 ( NM_020994.4 ) cDNA ORF clone, Homo sapiens(human) -> NP_066274.2 Homo sapiens cancer/testis antigen 2 (CTAG2), transcript variant 2, mRNA.

Price & Availability↑

CloneID	OHu20786
Clone ID Related Accession (Same CDS sequence)	NM_020994.4 , NM_020994.5
Accession Version	NM_020994.4	Documents for ORF clone product in default vector
Sequence Information	ORF Nucleotide Sequence (Length: 633bp) Protein sequence SNP
Vector	pcDNA3.1-C-(k)DYK or customized vector	User Manual
Clone information	Clone Map	MSDS
Tag on pcDNA3.1⁺/C-(K)DYK	C terminal DYKDDDDK tags
ORF Insert Method	CloneEZ™ Seamless cloning technology
Insert Structure	linear
Update Date	2018-06-29
Organism	Homo sapiens(human)
Product	cancer/testis antigen 2 isoform LAGE-1b
Comment	Comment: REVIEWED REFSEQ: This record has been curated by NCBI staff. The reference sequence was derived from AJ223040.1 and BC002833.2. This sequence is a reference standard in the RefSeqGene project. On Sep 14, 2013 this sequence version replaced NM_020994.3. Transcript Variant: This variant (2) has an additional segment in the 3' coding region which results in a frameshift, compared to variant 1. The encoded isoform (LAGE-1b, also known as LAGE-1L) is longer and has a distinct C-terminus, compared to isoform LAGE-1a. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Gene record to access additional publications. ##Evidence-Data-START## Transcript exon combination :: AJ223040.1, AJ012835.1 [ECO:0000332] RNAseq introns :: single sample supports all introns SAMEA1968968, SAMEA2148093 [ECO:0000348] ##Evidence-Data-END## COMPLETENESS: complete on the 3' end.

ATGCAGGCCG AAGGCCGGGG CACAGGGGGT TCGACGGGCG ATGCTGATGG CCCAGGAGGC 
CCTGGCATTC CTGATGGCCC AGGGGGCAAT GCTGGCGGCC CAGGAGAGGC GGGTGCCACG 
GGCGGCAGAG GTCCCCGGGG CGCAGGGGCA GCAAGGGCCT CGGGGCCGAG AGGAGGCGCC 
CCGCGGGGTC CGCATGGCGG TGCCGCTTCT GCGCAGGATG GAAGGTGCCC CTGCGGGGCC 
AGGAGGCCGG ACAGCCGCCT GCTTGAGTTG CACATCACGA TGCCTTTCTC GTCGCCCATG 
GAAGCGGAGC TGGTCCGCAG GATCCTGTCC CGGGATGCCG CACCGCTCCC CCGACCAGGG 
GCGGTTCTGA AGGACTTCAC CGTGTCCGGC AACCTACTGT TTATGTCAGT TCGGGACCAG 
GACAGGGAAG GCGCTGGGCG GATGAGGGTG GTGGGTTGGG GGCTGGGATC CGCCTCCCCG 
GAGGGGCAGA AAGCTAGAGA TCTCAGAACA CCCAAACACA AGGTCTCAGA ACAGAGACCT 
GGTACACCAG GCCCGCCGCC ACCCGAGGGA GCCCAGGGAG ATGGGTGCAG AGGTGTCGCC 
TTTAATGTGA TGTTCTCTGC CCCTCACATT TAG

The stop codons will be deleted if pcDNA3.1⁺/C-(K)DYK vector is selected.

RefSeq	NP_066274.2
CDS	65..697
Translation	MQAEGRGTGGSTGDADGPGGPGIPDGPGGNAGGPGEAGATGGRGPRGAGAARASGPRGGAPRGPHGGAASAQDGRCPCGARRPDSRLLELHITMPFSSPMEAELVRRILSRDAAPLPRPGAVLKDFTVSGNLLFMSVRDQDREGAGRMRVVGWGLGSASPEGQKARDLRTPKHKVSEQRPGTPGPPPPEGAQGDGCRGVAFNVMFSAPHI

Target ORF information:

RefSeq Version	NM_020994.4
Organism	Homo sapiens(human)
Definition	Homo sapiens cancer/testis antigen 2 (CTAG2), transcript variant 2, mRNA.

Target ORF information:

Epitope	DYKDDDDK
Bacterial selection	AMP^R
Mammalian selection	Neo^R
Vector	pcDNA3.1⁺/C-(K)DYK

NM_020994.4

ORF Insert Sequence:

ATGCAGGCCG AAGGCCGGGG CACAGGGGGT TCGACGGGCG ATGCTGATGG CCCAGGAGGC 
CCTGGCATTC CTGATGGCCC AGGGGGCAAT GCTGGCGGCC CAGGAGAGGC GGGTGCCACG 
GGCGGCAGAG GTCCCCGGGG CGCAGGGGCA GCAAGGGCCT CGGGGCCGAG AGGAGGCGCC 
CCGCGGGGTC CGCATGGCGG TGCCGCTTCT GCGCAGGATG GAAGGTGCCC CTGCGGGGCC 
AGGAGGCCGG ACAGCCGCCT GCTTGAGTTG CACATCACGA TGCCTTTCTC GTCGCCCATG 
GAAGCGGAGC TGGTCCGCAG GATCCTGTCC CGGGATGCCG CACCGCTCCC CCGACCAGGG 
GCGGTTCTGA AGGACTTCAC CGTGTCCGGC AACCTACTGT TTATGTCAGT TCGGGACCAG 
GACAGGGAAG GCGCTGGGCG GATGAGGGTG GTGGGTTGGG GGCTGGGATC CGCCTCCCCG 
GAGGGGCAGA AAGCTAGAGA TCTCAGAACA CCCAAACACA AGGTCTCAGA ACAGAGACCT 
GGTACACCAG GCCCGCCGCC ACCCGAGGGA GCCCAGGGAG ATGGGTGCAG AGGTGTCGCC 
TTTAATGTGA TGTTCTCTGC CCCTCACATT TAG

The stop codons will be deleted if pcDNA3.1⁺/C-(K)DYK vector is selected.

CTAG2 ( NM_020994.5 ) cDNA ORF clone, Homo sapiens(human) -> NP_066274.2 Homo sapiens cancer/testis antigen 2 (CTAG2), transcript variant 2, mRNA.

Price & Availability↑

CloneID	OHu20786
Clone ID Related Accession (Same CDS sequence)	NM_020994.4 , NM_020994.5
Accession Version	NM_020994.5 Latest version!	Documents for ORF clone product in default vector
Sequence Information	ORF Nucleotide Sequence (Length: 633bp) Protein sequence SNP
Vector	pcDNA3.1-C-(k)DYK or customized vector	User Manual
Clone information	Clone Map	MSDS
Tag on pcDNA3.1⁺/C-(K)DYK	C terminal DYKDDDDK tags
ORF Insert Method	CloneEZ™ Seamless cloning technology
Insert Structure	linear
Update Date	2019-09-28
Organism	Homo sapiens(human)
Product	cancer/testis antigen 2 isoform LAGE-1b
Comment	Comment: REVIEWED REFSEQ: This record has been curated by NCBI staff. The reference sequence was derived from AJ223040.1 and BC002833.2. This sequence is a reference standard in the RefSeqGene project. On Jun 2, 2019 this sequence version replaced NM_020994.4. Transcript Variant: This variant (2) has an additional segment in the 3' coding region which results in a frameshift, compared to variant 1. The encoded isoform (LAGE-1b, also known as LAGE-1L) is longer and has a distinct C-terminus, compared to isoform LAGE-1a. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Gene record to access additional publications. ##Evidence-Data-START## Transcript exon combination :: AJ012835.1, BC002833.2 [ECO:0000332] RNAseq introns :: single sample supports all introns SAMEA1968968, SAMEA2148093 [ECO:0000348] ##Evidence-Data-END## COMPLETENESS: complete on the 3' end.

ATGCAGGCCG AAGGCCGGGG CACAGGGGGT TCGACGGGCG ATGCTGATGG CCCAGGAGGC 
CCTGGCATTC CTGATGGCCC AGGGGGCAAT GCTGGCGGCC CAGGAGAGGC GGGTGCCACG 
GGCGGCAGAG GTCCCCGGGG CGCAGGGGCA GCAAGGGCCT CGGGGCCGAG AGGAGGCGCC 
CCGCGGGGTC CGCATGGCGG TGCCGCTTCT GCGCAGGATG GAAGGTGCCC CTGCGGGGCC 
AGGAGGCCGG ACAGCCGCCT GCTTGAGTTG CACATCACGA TGCCTTTCTC GTCGCCCATG 
GAAGCGGAGC TGGTCCGCAG GATCCTGTCC CGGGATGCCG CACCGCTCCC CCGACCAGGG 
GCGGTTCTGA AGGACTTCAC CGTGTCCGGC AACCTACTGT TTATGTCAGT TCGGGACCAG 
GACAGGGAAG GCGCTGGGCG GATGAGGGTG GTGGGTTGGG GGCTGGGATC CGCCTCCCCG 
GAGGGGCAGA AAGCTAGAGA TCTCAGAACA CCCAAACACA AGGTCTCAGA ACAGAGACCT 
GGTACACCAG GCCCGCCGCC ACCCGAGGGA GCCCAGGGAG ATGGGTGCAG AGGTGTCGCC 
TTTAATGTGA TGTTCTCTGC CCCTCACATT TAG

The stop codons will be deleted if pcDNA3.1⁺/C-(K)DYK vector is selected.

RefSeq	NP_066274.2
CDS	65..697
Translation	MQAEGRGTGGSTGDADGPGGPGIPDGPGGNAGGPGEAGATGGRGPRGAGAARASGPRGGAPRGPHGGAASAQDGRCPCGARRPDSRLLELHITMPFSSPMEAELVRRILSRDAAPLPRPGAVLKDFTVSGNLLFMSVRDQDREGAGRMRVVGWGLGSASPEGQKARDLRTPKHKVSEQRPGTPGPPPPEGAQGDGCRGVAFNVMFSAPHI

Target ORF information:

RefSeq Version	NM_020994.5
Organism	Homo sapiens(human)
Definition	Homo sapiens cancer/testis antigen 2 (CTAG2), transcript variant 2, mRNA.

Target ORF information:

Epitope	DYKDDDDK
Bacterial selection	AMP^R
Mammalian selection	Neo^R
Vector	pcDNA3.1⁺/C-(K)DYK

NM_020994.5

ORF Insert Sequence:

ATGCAGGCCG AAGGCCGGGG CACAGGGGGT TCGACGGGCG ATGCTGATGG CCCAGGAGGC 
CCTGGCATTC CTGATGGCCC AGGGGGCAAT GCTGGCGGCC CAGGAGAGGC GGGTGCCACG 
GGCGGCAGAG GTCCCCGGGG CGCAGGGGCA GCAAGGGCCT CGGGGCCGAG AGGAGGCGCC 
CCGCGGGGTC CGCATGGCGG TGCCGCTTCT GCGCAGGATG GAAGGTGCCC CTGCGGGGCC 
AGGAGGCCGG ACAGCCGCCT GCTTGAGTTG CACATCACGA TGCCTTTCTC GTCGCCCATG 
GAAGCGGAGC TGGTCCGCAG GATCCTGTCC CGGGATGCCG CACCGCTCCC CCGACCAGGG 
GCGGTTCTGA AGGACTTCAC CGTGTCCGGC AACCTACTGT TTATGTCAGT TCGGGACCAG 
GACAGGGAAG GCGCTGGGCG GATGAGGGTG GTGGGTTGGG GGCTGGGATC CGCCTCCCCG 
GAGGGGCAGA AAGCTAGAGA TCTCAGAACA CCCAAACACA AGGTCTCAGA ACAGAGACCT 
GGTACACCAG GCCCGCCGCC ACCCGAGGGA GCCCAGGGAG ATGGGTGCAG AGGTGTCGCC 
TTTAATGTGA TGTTCTCTGC CCCTCACATT TAG

The stop codons will be deleted if pcDNA3.1⁺/C-(K)DYK vector is selected.

PubMed

Reexpression of LSAMP inhibits tumor growth in a preclinical osteosarcoma model.
Molecular cancer1393(2014 Apr)
Bar?y T,Kresse SH,Sk?rn M,Stabell M,Castro R,Lauvrak S,Llombart-Bosch A,Myklebost O,Meza-Zepeda LA

Genome-wide association analysis of red blood cell traits in African Americans: the COGENT Network.
Human molecular genetics22(12)2529-38(2013 Jun)
Chen Z,Tang H,Qayyum R,Schick UM,Nalls MA,Handsaker R,Li J,Lu Y,Yanek LR,Keating B,Meng Y,van Rooij FJ,Okada Y,Kubo M,Rasmussen-Torvik L,Keller MF,Lange L,Evans M,Bottinger EP,Linderman MD,Ruderfer DM,Hakonarson H,Papanicolaou G,Zonderman AB,Gottesman O,,,Thomson C,Ziv E,Singleton AB,Loos RJ,Sleiman PM,Ganesh S,McCarroll S,Becker DM,Wilson JG,Lettre G,Reiner AP

NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine.
PloS one7(2)e32165(2012)
Pollack SM,Li Y,Blaisdell MJ,Farrar EA,Chou J,Hoch BL,Loggers ET,Rodler E,Eary JF,Conrad EU 3rd,Jones RL,Yee C

Evaluation of LAGE-1 and NY-ESO-1 expression in multiple myeloma patients to explore possible benefits of their homology for immunotherapy.
Cancer immunity111(2011 Jan)
de Carvalho F,Vettore AL,Inaoka RJ,Karia B,Andrade VC,Gnjatic S,Jungbluth AA,Colleoni GW

Cancer/testis antigens: an expanding family of targets for cancer immunotherapy.
Immunological reviews18822-32(2002 Oct)
Scanlan MJ,Gure AO,Jungbluth AA,Old LJ,Chen YT

- Most Popular Services
  - 人工遺伝子合成& DNA合成-納期保証
- Services & Products

見積依頼

Eメール

japanmarket@genscript.com

電話

03-6811-6572

FAX

03-6811-6573
050-3174-7589(受注専用)

オンラインフォーム

オンライン注文

CTAG2 cDNA ORF clone, Homo sapiens(human)

Gene

Clones

gRNAs

Related articles in PubMed

Target ORF information:

Target ORF information:

ORF Insert Sequence:

Target ORF information:

Target ORF information:

ORF Insert Sequence:

Target ORF information:

Target ORF information:

ORF Insert Sequence:

Most Popular Services

Services & Products

見積依頼

Eメール

電話

FAX

オンラインフォーム

サポート

会社情報

サポート

会社情報